You are viewing: US Gastrointestinal Products Market analysis

The US Gastrointestinal Products Market was valued at $2510.1 Million in 2024 and projected to reach to $3663.9 Million by 2029, representing a compound annual growth rate of 7.9%. The US gastrointestinal products market is positioned for sustained growth through 2029, supported by an aging population with higher incidence of GI disorders and increased healthcare expenditure.

US Gastrointestinal Products Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Gastrointestinal Products Market Trends and Insights

  • This robust expansion reflects the US healthcare sector's increasing focus on digestive health management and the rising prevalence of gastrointestinal disorders across the American population.
  • The US market is driven by advanced pharmaceutical formulations, over-the-counter remedies, and diagnostic solutions tailored to meet diverse patient needs. In the US, the gastrointestinal products market benefits from strong healthcare infrastructure, high consumer awareness, and significant investment in research and development.
  • The US pharmaceutical industry continues to innovate with novel therapeutics for conditions such as irritable bowel syndrome, acid reflux, and inflammatory bowel disease.
  • Between 2024 and 2029, the US market is expected to experience sustained growth fueled by an aging population, increased healthcare spending, and expanding access to specialized gastrointestinal treatments. The competitive landscape in the US remains dynamic, with both established pharmaceutical giants and emerging biotech companies vying for market share.
  • The US regulatory environment, governed by the FDA, ensures product safety and efficacy while facilitating faster market entry for breakthrough therapies.
  • Strategic partnerships, acquisitions, and product launches will continue to shape the US gastrointestinal products market trajectory through 2029..

Key Market Statistics

  • CAGR (2024-2029) 7.9% CAGR
  • Market Size, 2024 ~USD 2510.1 Million
  • Forecast, 2029 ~USD 3663.9 Million
  • Country US

US Gastrointestinal Products Market Overview

Market Valuation Growth :

The US gastrointestinal products market reached $2,510.1 million in 2024 and is expected to grow to $3,663.9 million by 2029, driven by increasing healthcare spending and consumer awareness of digestive health.

Strong CAGR Performance :

The US market is expanding at a 7.9% CAGR, outpacing the global growth rate of 6.1%, indicating robust demand for GI products within the American healthcare system.

Rising GI Disorder Prevalence :

Increasing prevalence of gastrointestinal disorders across the American population, including IBS, GERD, and inflammatory bowel disease, is fueling demand for specialized treatment products and solutions.

Healthcare Focus on Digestive Health :

US healthcare providers and pharmaceutical companies are prioritizing digestive health management, leading to innovation in product development and expanded treatment options for patients.

US Gastrointestinal Products Market Dynamics

  • Pharmaceutical innovation, coupled with growing consumer interest in preventive digestive health, will drive market expansion.
  • The US market's outperformance relative to global growth reflects strong healthcare infrastructure, high treatment adoption rates, and robust reimbursement mechanisms that encourage product development and patient access to advanced GI therapies. Key growth drivers include rising obesity rates contributing to GERD prevalence, expanding over-the-counter product availability, and increased clinical awareness among US physicians.
  • Digital health integration and personalized medicine approaches are expected to enhance treatment outcomes and market penetration.
  • Strategic investments by major pharmaceutical companies in US GI product portfolios will further accelerate market growth through 2029..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US gastrointestinal products market is valued at $2,510.1 million in 2024 and will reach $3,663.9 million by 2029, growing at a 7.9% CAGR.
    • The US market is driven by rising gastrointestinal disorder prevalence, an aging population, and increased healthcare spending on digestive health.
    • The US pharmaceutical industry leads innovation in IBS, IBD, and acid reflux treatments, supported by robust FDA regulatory frameworks.
    • The US competitive landscape features both multinational pharmaceutical corporations and specialized biotech firms pursuing market expansion through R&D and strategic acquisitions.

    Gastrointestinal Products Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment IRRITABLE BOWEL SYNDROME (IBS) (Disease)
    Forecast Period 2024-2029
    Growth Rate CAGR of 6.1% from 2024 to 2029
    Largest Segment ENDOSCOPY DEVICES (Device)
    Market Size Base Year (Billions) ~USD 14.65 (2024)
    Revenue Forecast (Billions) ~USD 19.7 (2029)
    Segments Covered Device, Type, Disease, End User

    US Gastrointestinal Products Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Ablation Devices
    • Biopsy Devices
    • Endoscopy Devices
    • Motility Testing Devices
    • Other Gastroenterology/ Gastrointestinal Devices
    • Other Gastroenterology/Gastrointestinal Devices
    • Ph Monitoring Devices
    • Stenting Devices

    By Type

    • 4-Hour Ph Impedance Testing Devices
    • Ambulatory Ph Monitoring Systems
    • Anorectal Manometry Devices
    • Biliary Stents
    • Capsule Endoscopes
    • Colonic Stents
    • Cryoablation Devices
    • Duodenal Stents
    • Esophageal Manometry Devices
    • Esophageal Ph Monitoring Catheters
    • Esophageal Stents
    • Flexible Endoscopes
    • Gastric Balloons
    • Gastrointestinal Tubes
    • Hemorrhoid Treatment Devices
    • Laser Ablation Devices
    • Microwave Ablation Devices
    • Needle Biopsy Devices
    • Other Ablation Devices
    • Other Biopsy Devices
    • Other Endoscopy Devices
    • Other Motility Testing Devices
    • Pancreatic Stents
    • Radiofrequency Ablation Devices
    • Rigid Endoscopes
    • Wireless Ph Monitoring Capsules

    By Disease

    • Gastroesophageal Reflux Disease (Gerd)
    • Gastrointestinal Cancers
    • Inflammatory Bowel Disease (Ibd)
    • Irritable Bowel Syndrome (Ibs)
    • Other Diseases

    By End User

    • Ambulatory Surgical Centers & Independent Diagnostic Centers
    • Clinics
    • Hospitals
    • Other End Users

    US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS1432.21516.61612.21715.91826.71945.42072.32455.58.8
    CLINICS617.6641.2668.3697.2727.7759.8793.5921.76.6
    HOSPITALS1860.819912138.8230024742662.42865.52665.14.5
    OTHER END USERS548.5571.1596.9624.6653.7684.5716.9835.27
    TOTAL4459.14719.95016.25337.75682.16052.16448.36877.66.5

    Target Audience

    • Pharmaceutical Companies : US-based and international pharma firms need detailed market data to guide R&D investments, product development priorities, and commercial strategies for the high-growth American GI market.
    • Medical Device Manufacturers : Device companies require US market intelligence to identify opportunities in diagnostic and therapeutic GI devices, understand reimbursement landscapes, and plan product launches.
    • Healthcare Investors : Private equity, venture capital, and institutional investors need comprehensive US market analysis to evaluate investment opportunities in GI healthcare companies and assess portfolio performance.
    • Healthcare Consultants : Management consulting firms advising healthcare clients require detailed US market data to support strategic planning, market entry analysis, and competitive positioning recommendations.
    • Healthcare Providers & Insurers : Hospital systems, clinics, and insurance companies need market insights to optimize GI product procurement, understand treatment trends, and plan healthcare delivery strategies for US populations.

    Reasons to Buy this Report

    • Accurate US Market Sizing : Obtain precise valuation data specific to the US market ($2,510.1M in 2024) with detailed forecasts through 2029, enabling accurate financial planning and investment decisions for US operations.
    • Competitive Intelligence : Understand the US competitive landscape, market dynamics, and growth drivers unique to the American healthcare system to identify opportunities and benchmark against regional competitors.
    • Strategic Market Entry : Leverage US-specific insights on prevalence rates, treatment adoption patterns, and reimbursement mechanisms to develop targeted market entry strategies and product positioning for maximum impact.
    • Investment Decision Support : Make informed investment and resource allocation decisions based on the US market's 7.9% CAGR outperformance versus global rates, supporting business case development for US expansion.
    • Regulatory and Market Compliance : Access US-specific regulatory environment insights, healthcare infrastructure details, and market access pathways essential for product launches and compliance with American healthcare standards.

    Frequently asked questions

    What is the current size of the US gastrointestinal products market?

    The US gastrointestinal products market was valued at $2,510.1 million in 2024.

    What is the projected size of the US gastrointestinal products market by 2029?

    The US gastrointestinal products market is projected to reach $3,663.9 million by 2029.

    What is the growth rate of the US gastrointestinal products market?

    The US gastrointestinal products market is expected to grow at a compound annual growth rate of 7.9% from 2024 to 2029.

    What factors are driving growth in the US gastrointestinal products market?

    Key growth drivers in the US include rising prevalence of gastrointestinal disorders, an aging population, increased healthcare spending, and continuous pharmaceutical innovation in digestive health treatments.

    Who are the major competitors in the US gastrointestinal products market?

    The US market includes multinational pharmaceutical companies, specialized biotech firms, and generic drug manufacturers competing through product innovation, strategic partnerships, and market expansion initiatives.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

    Gastroenterology Products Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.

    Country-Level Analysis

    The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country)

    • Approach 1:
      • Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
    • Approach 2:
      • Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    To know about the assumptions considered for the study, Request for Free Sample Report

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.

    Market Definition

    Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.

    Key Stakeholders

    • Medical Device Manufacturers
    • Healthcare Institutions (hospitals and outpatient clinics)
    • Distributors and Suppliers
    • Research Institutes
    • Health Insurance Payers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries

    Get the Full Gastrointestinal Products Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status